Forum

Your browser does not seem to support JavaScript. As a result, your viewing experience will be diminished, and you have been placed in read-only mode.

Please download a browser that supports JavaScript, or enable it if it's disabled (i.e. NoScript).

PAAB Notice

The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

35 - At a recent visit to my physician, I ran across a display of disease information brochures (eg, diabetes) branded with a product name in the waiting room. I was always under the impression that this would be considered DTC and that we are not allowed to provide branded disease information to the general public. Can you clarify?

DTCA/I, consumer secondary audience

1 Posts 1 Posters 252 Views

J Offline
J Offline
Jennifer Carroll

wrote on last edited by

#1

Your example would be considered "advertising" because it links the drug name and the therapeutic use. This would be a violation of the Food and Drugs Act section c01.044. PAAB provides an advisory service to avoid this type of violation.
1 Reply Last reply

0